Companies: 10,795·Total market cap: $144.5T
Immutep Limited

Immutep Limited

IMMPNASDAQHealthcare● Active
$0.37
$-0.01(-2.04%)
Market Cap$54365531
P/E Ratio
52W High$3.53
52W Low$0.29

Immutep Limited (IMMP) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

IMMP · cash on hand · updated Jun 30, 2025

Core cash position

Cash & Short-Term Investments (CCE + ST Investments)
$129.7M -28.7% vs prior year
FY · as of Jun 30, 2025 · Reported in AUD
Cash & Cash Equiv. (CCE)
$67.4M
cashAndCashEquivalents
Short-Term Investments
$62.3M
shortTermInvestments
YoY Change vs Prior Year
-28.7%
vs prior fiscal year
Latest Quarter
$99.1M
Q4 2025
Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in AUD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: June 30, 2025

Net cash vs debt

Cash & ST Investments$129.7MCash on Hand
Total Debt$1.6MTotal Debt
Net Cash / Net Debt+$128.1MNet Cash Position
Cash vs Debt Ratio
Cash 99%Debt 1%

Immutep Limited has a net cash position of $128.1M, holding more cash than debt.

Net Cash = Cash & ST Investments − Total Debt$129.7M$1.6M = +$128.1M

Cash on hand history

YoY Increase
YoY Decrease
Latest Year
IMMP annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

DateCash & ST InvestmentsYoY Change
Jun 30, 2025Latest$129.7M-28.7%
Jun 30, 2024$181.9M+47.4%
Jun 30, 2023$123.4M+54.3%
Jun 30, 2022$80.0M+33.0%
Jun 30, 2021$60.1M+128.4%
IMMP cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

#CompanyCash & ST Inv.Cash/MCap
#1
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$28.12B7.6%
#2
Johnson & Johnson
Johnson & Johnson
JNJ
$20.10B3.6%
#3
Eli Lilly and Company
Eli Lilly and Company
LLY
$7.27B0.7%
#4
AbbVie Inc.
AbbVie Inc.
ABBV
$5.26B1.3%
#5
Immutep Limited
Immutep LimitedYOU
IMMP
$129.7M238.6%
Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Immutep Limited (IMMP) cash on hand as of June 30, 2025 is $129.7M, comprising $67.4M in cash and cash equivalents (CCE) plus $62.3M in short-term investments — reported as Immutep Limited cash and short-term investments on the balance sheet (10-K filing). Also referred to as Immutep Limited cash reserves or cash position.

Immutep Limited annual cash on hand history shows decreased -28.7% in 2025: decreased -28.7% in 2025. Immutep Limited cash reserves in 2025 reflect the company's capital allocation strategy.

Immutep Limited carries total debt of $1.6M against cash of $129.7M, resulting in a net cash position of +$128.1M. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.

Frequently asked questions

IMMP cash on hand · 5 questions

As of June 30, 2025, Immutep Limited (IMMP) has $129,692,994 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $67,408,215 in cash and cash equivalents (CCE) plus $62,284,779 in short-term investments. Latest quarter (December 31, 2025): $99,129,499. Data sourced from the annual 10-K filing via FMP.

IMMP cash on handIMMP cash reservesIMMP cash 2025how much cash does IMMP have

Source: FMP /balance-sheet-statement · US GAAP · Immutep Limited · Immutep Limited SEC 10-K & 10-Q filings · US GAAP · Last updated: June 30, 2025